Related Experiment Videos
Do myelin-directed antibodies predict multiple sclerosis?
1Montreal Neurological Institute, McGill University, Montreal.
The New England Journal of Medicine
|July 11, 2003
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Abnormal B-Cell Exosome Proapoptotic and Antiapoptotic Cargo in Multiple Sclerosis: Potential Implication in Progressive Disease Biology.
Neurology(R) neuroimmunology & neuroinflammation·2026
Same author
Bruton's tyrosine kinase inhibitors: a new class of multiple sclerosis therapeutics.
The Lancet. Neurology·2026
Same author
Progression to Wheelchair in Secondary Progressive Multiple Sclerosis and Impact of Siponimod: Post Hoc Analyses From the EXPAND Study.
European journal of neurology·2026
Same author
Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trials.
Lancet (London, England)·2026
Same author
The gut microbiome in pediatric-onset acquired demyelinating syndromes by myelin oligodendrocyte glycoprotein antibody status.
Multiple sclerosis and related disorders·2026
Same journal
Caring for an Aging America - The Looming Crisis of the Long-Term-Care Workforce.
The New England journal of medicine·2026
Same journal
Colliding Forces - The Aging of the Baby Boom Generation and Contracting Nursing-Home Supply.
The New England journal of medicine·2026
Same journal
Mandated State-Level Surveillance of Assisted Reproductive Technology - An Emerging Threat in the United States.
The New England journal of medicine·2026
Same journal
Ebola at 50 - Lessons for Outbreak Response and Preparedness.
The New England journal of medicine·2026